Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15298996 | 0.95 | PTGS1 (0.34) | TDP1CYP2C9PTGS1AKR1C3MAPT | |
| SCHEMBL137715 | 0.95 | PTGS1 (0.34) | TDP1CYP2C9PTGS1AKR1C3MAPT | |
| SCHEMBL28861159 | 0.92 | PTGS1 (0.33) | CYP2C9PTGS1AKR1C3MAPT | |
| Acrylic Acid SCHEMBL5423268 | 0.86 | LMNA (0.46) | CYP2C9PTGS1AKR1C3 | |
| SCHEMBL4947083 | 0.83 | ALDH1A1 (0.58) | CYP2C9 | |
| Methacrylic Acid SCHEMBL1443532 | 0.82 | HTT (0.39) | TDP1CYP2C9PTGS1AKR1C3MAPT | |
| SCHEMBL22193118 | 0.81 | CYP2C9 (0.34) | CYP2C9PTGS1AKR1C3 | |
| Methacrylic Acid SCHEMBL8425141 | 0.80 | TDP1 (0.33) | TDP1CYP2C9PTGS1AKR1C3MAPT | |
| SCHEMBL14020469 | 0.80 | — | — | |
| Methacrylic Acid SCHEMBL8425146 | 0.80 | TDP1 (0.33) | TDP1CYP2C9PTGS1AKR1C3MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8524768-B2 | Antioxidants for preventing and treating diseases caused by oxidative stress | GITLIN ISAAK GRIGORIEVICH (RU) | 2013-09-03 | — | — | US | disclosed |
| US-20090170789-A1 | Antioxidants for preventing and treating diseases caused by oxidative stress | GITLIN ISAAK GRIGORIEVICH | 2009-07-02 | — | — | US | disclosed |
| US-6828368-B2 | Useful for the preparation of a heat-sensitive tacky adhesive having excellent adhesive strength and blocking resistance; solid plasticizer | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2004-12-07 | — | — | US | disclosed |
| EP-1298121-A1 | BIS(CIS-3,3,5-TRIMETHYLCYCLOHEXYL) PHTHALATE, PROCESS FOR PRODUCING THE SAME, AND THERMOPLASTIC RESIN COMPOSITION | Daicel Chemical Industries, Ltd. (JP) | 2003-04-02 | — | — | EP | disclosed |
| US-20020193482-A1 | Bis(cis-3,3,5-trimethylcyclohexyl) phthalate, process for producing the same, and thermoplastic resin composition | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2002-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020193482-A1 | Bis(cis-3,3,5-trimethylcyclohexyl) phthalate, process for producing the same, and thermoplastic resin composition | PSMA3, CDH1, DPY30 | TDP1 2932/4885CYP2C9 671/4885PTGS1 2869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.